Vandana Gupta Abramson

Summary

Affiliation: Vanderbilt University
Country: USA

Publications

  1. ncbi Cyclin D1b in human breast carcinoma and coexpression with cyclin D1a is associated with poor outcome
    Vandana Gupta Abramson
    Department of Medicine, University of Pennsylvania, PA, USA
    Anticancer Res 30:1279-85. 2010
  2. ncbi Clinical utility of serum tumor markers and circulating tumor cell assays in the treatment of breast cancer
    Vandana G Abramson
    Division of Hematology Oncology, Department of Medicine, Vanderbilt University, Vanderbilt Ingram Cancer Center, Nashville, TN 37212, USA
    Curr Treat Options Oncol 12:403-11. 2011

Detail Information

Publications2

  1. ncbi Cyclin D1b in human breast carcinoma and coexpression with cyclin D1a is associated with poor outcome
    Vandana Gupta Abramson
    Department of Medicine, University of Pennsylvania, PA, USA
    Anticancer Res 30:1279-85. 2010
    ..Our objectives were to determine whether cyclin D1b is expressed in human breast carcinomas and to characterize the relationship of this protein to both cyclin D1a and clinical outcome in breast cancer patients...
  2. ncbi Clinical utility of serum tumor markers and circulating tumor cell assays in the treatment of breast cancer
    Vandana G Abramson
    Division of Hematology Oncology, Department of Medicine, Vanderbilt University, Vanderbilt Ingram Cancer Center, Nashville, TN 37212, USA
    Curr Treat Options Oncol 12:403-11. 2011
    ..CTCs hold great promise in the management of breast cancer and future studies will help delineate their role more appropriately...